Michael Haugbro

Michael Haugbro is a highly skilled scientist currently serving as a Senior Scientist at HemoGenyx Pharmaceuticals Ltd. since June 2021, with previous roles as Scientist II and Scientist. Prior to this, Michael completed a PhD in Chemistry at Princeton University from July 2015 to May 2021. Academic experience includes undergraduate research positions at New York University and Vassar College, along with research internships at Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College. Educational background includes a Bachelor of Science in Chemistry from New York University and a high school diploma from Hunter College High School.